• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.88% Nasdaq Down1.33%

    Vanda Pharmaceuticals, Inc. (VNDA)

    7.80 Down 0.22(2.74%) 9:32AM EST - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.4
    Mean Recommendation (last week):1.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:19.80
    Median Target:18.00
    High Target:30.00
    Low Target:15.00
    No. of Brokers:5

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 9, 2015Canaccord GenuityInitiated Buy
    Mar 10, 2010HapoalimInitiated Outperform
    Dec 9, 2009Jefferies & CoInitiated Buy
    Jul 29, 2008Banc of America SecDowngradeBuyNeutral
    Jul 29, 2008JP MorganDowngradeOverweightNeutral
    Jul 28, 2008Caris & CompanyDowngradeBuyAbove Average
    May 2, 2008Caris & CompanyInitiated Buy
    Sep 10, 2007Banc of America SecInitiated Buy
    May 8, 2007CitigroupInitiated Hold
    Feb 14, 2007Friedman BillingsInitiated Outperform

    More Upgrades & Downgrades for VNDA

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3332

    Data provided by Thomson/First Call

    Currency in USD.